EP1637134A4 - COMPOSITION FOR THE PREVENTION AND TREATMENT OF VARICES - Google Patents
COMPOSITION FOR THE PREVENTION AND TREATMENT OF VARICESInfo
- Publication number
- EP1637134A4 EP1637134A4 EP04746413A EP04746413A EP1637134A4 EP 1637134 A4 EP1637134 A4 EP 1637134A4 EP 04746413 A EP04746413 A EP 04746413A EP 04746413 A EP04746413 A EP 04746413A EP 1637134 A4 EP1637134 A4 EP 1637134A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- prevention
- treatment
- composition
- varicose veins
- varicose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010046996 Varicose vein Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 208000027185 varicose disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003177339 | 2003-06-20 | ||
PCT/JP2004/008944 WO2004112777A1 (ja) | 2003-06-20 | 2004-06-18 | 下肢静脈瘤予防・治療用組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1637134A1 EP1637134A1 (en) | 2006-03-22 |
EP1637134A4 true EP1637134A4 (en) | 2010-01-27 |
Family
ID=33534955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04746413A Withdrawn EP1637134A4 (en) | 2003-06-20 | 2004-06-18 | COMPOSITION FOR THE PREVENTION AND TREATMENT OF VARICES |
Country Status (5)
Country | Link |
---|---|
US (1) | US20070098787A1 (ja) |
EP (1) | EP1637134A4 (ja) |
JP (1) | JP4870430B2 (ja) |
CA (1) | CA2529735C (ja) |
WO (1) | WO2004112777A1 (ja) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080171128A1 (en) * | 2007-01-11 | 2008-07-17 | Gloria Cagampang | Storage stable creme filling fortified with omega-3 fatty acids |
US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
UA102477C2 (en) * | 2008-01-10 | 2013-07-10 | Такеда Фармасьютикал Компани Лимитед | Capsule composition |
WO2010028067A1 (en) | 2008-09-02 | 2010-03-11 | Amarin Corporation Plc | Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same |
US9308261B2 (en) * | 2008-10-13 | 2016-04-12 | Pregnant Princess & Co. Ltd. | Compositions and methods for treating varicose veins |
CN104856985B (zh) | 2009-04-29 | 2019-01-04 | 阿马里纳制药爱尔兰有限公司 | 稳定的药物组合物和使用其的方法 |
CN104042617A (zh) | 2009-04-29 | 2014-09-17 | 阿马里纳药物爱尔兰有限公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
KR20120016677A (ko) | 2009-06-15 | 2012-02-24 | 아마린 파마, 인크. | 병용 스타틴 요법을 받는 대상체에서 ldl-c 수준을 상승시키지 않으면서 트리글리세리드를 저하시키기 위한 조성물 및 방법 |
KR101798670B1 (ko) | 2009-09-23 | 2017-11-16 | 아마린 코포레이션 피엘씨 | 오메가-3 지방산 및 스타틴의 히드록시-유도체를 포함하는 제약 조성물 및 그의 사용 방법 |
US8722131B2 (en) | 2010-09-07 | 2014-05-13 | Dsm Nutritional Products Ag | Comestible emulsions |
NZ611606A (en) | 2010-11-29 | 2015-10-30 | Amarin Pharmaceuticals Ie Ltd | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
WO2013070735A1 (en) | 2011-11-07 | 2013-05-16 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
JP6307442B2 (ja) | 2012-01-06 | 2018-04-04 | アマリン ファーマシューティカルス アイルランド リミテッド | 対象の高感度(hs−crp)のレベルを低下させる組成物および方法 |
EP2861227A4 (en) | 2012-06-17 | 2016-01-27 | Matinas Biopharma Inc | OMEGA-3 PENTAIC ACID COMPOSITIONS AND METHODS OF USE |
DK3363433T3 (da) | 2012-06-29 | 2021-03-08 | Amarin Pharmaceuticals Ie Ltd | Fremgangsmåder til reduktion af risikoen for en kardiovaskulær begivenhed i et individ i statinbehandling ved anvendelse af eicosapentaensyreetylester |
US20150265566A1 (en) | 2012-11-06 | 2015-09-24 | Amarin Pharmaceuticals Ireland Limited | Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy |
US9814733B2 (en) | 2012-12-31 | 2017-11-14 | A,arin Pharmaceuticals Ireland Limited | Compositions comprising EPA and obeticholic acid and methods of use thereof |
US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
US9662307B2 (en) | 2013-02-19 | 2017-05-30 | The Regents Of The University Of Colorado | Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof |
US9283201B2 (en) | 2013-03-14 | 2016-03-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating or preventing obesity in a subject in need thereof |
US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
WO2015195662A1 (en) | 2014-06-16 | 2015-12-23 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids |
BR112017013445B1 (pt) * | 2014-12-23 | 2021-11-23 | Evonik Operations Gmbh | Processo para aumentar a estabilidade de uma composição que compreende ácidos graxos ômega 6 poli-insaturados e uso da composição de produto |
US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
WO2017208741A1 (ja) | 2016-06-02 | 2017-12-07 | 不二製油グループ本社株式会社 | 高度不飽和脂肪酸含有チョコレート様食品 |
BR112019018943B1 (pt) * | 2017-03-21 | 2023-03-07 | Fuji Oil Holdings Inc | Chocolate para cobertura de sorvete e método para suprimir a geração de off-flavors |
TW201900160A (zh) | 2017-05-19 | 2019-01-01 | 愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 | 用於降低腎功能下降之個體中的三酸甘油酯之組合物及方法 |
US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
MA51765A (fr) | 2018-09-24 | 2020-12-16 | Amarin Pharmaceuticals Ie Ltd | Procédés de réduction du risque d'événements cardiovasculaires chez un sujet |
KR20240012390A (ko) | 2021-04-21 | 2024-01-29 | 애머린 파마슈티칼스 아일랜드 리미티드 | 심부전의 위험을 감소시키는 방법 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0930962A (ja) * | 1995-07-21 | 1997-02-04 | Nisshin Oil Mills Ltd:The | 医療用油脂含有組成物 |
WO2001019158A2 (en) * | 1999-09-10 | 2001-03-22 | Ceteris Holding B.V.-Amsterdam (Olanda) - Succursale Di Lugano | An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
WO2001084961A2 (en) * | 2000-05-08 | 2001-11-15 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58180423A (ja) * | 1982-04-16 | 1983-10-21 | Nippon Suisan Kaisha Ltd | 末梢血流障害治療剤 |
DK0457950T3 (da) * | 1990-05-23 | 1994-03-07 | Nestle Sa | Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme |
GB9300125D0 (en) * | 1993-01-06 | 1993-03-03 | Scotia Holdings Plc | Compositions containing esters of unsaturated fatty acids |
JPH06298642A (ja) * | 1993-04-14 | 1994-10-25 | Japan Tobacco Inc | 高度不飽和脂肪酸含有o/w型乳剤及びその酸化防止方法 |
JPH0725816A (ja) * | 1993-07-08 | 1995-01-27 | Yoshihisa Matsuda | ポリエン酸類の包接化合物 |
IT1274734B (it) * | 1994-08-25 | 1997-07-24 | Prospa Bv | Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti |
FR2742155B1 (fr) * | 1995-12-12 | 1998-02-13 | Innothera Lab Sa | Utilisation de derives heteroaromatiques et tricycliques du 1,4-dihydro-1,4-dioxonaphtalene, nouveaux composes obtenus et leur application en therapeutique |
AU718164B2 (en) * | 1996-04-29 | 2000-04-06 | W.L. Gore & Associates, Inc. | Device for restoring competence to venous valves |
FR2790758A1 (fr) * | 1999-03-09 | 2000-09-15 | Commissariat Energie Atomique | Solubilisation d'acides gras polyinsatures et de leurs derives par formation de complexes d'inclusion avec une cyclodextrine et leur utilisation dans des compositions pharmaceutiques, cosmetiques ou alimentaires |
-
2004
- 2004-06-18 CA CA2529735A patent/CA2529735C/en not_active Expired - Fee Related
- 2004-06-18 US US10/561,274 patent/US20070098787A1/en not_active Abandoned
- 2004-06-18 JP JP2005507294A patent/JP4870430B2/ja not_active Expired - Lifetime
- 2004-06-18 WO PCT/JP2004/008944 patent/WO2004112777A1/ja active Application Filing
- 2004-06-18 EP EP04746413A patent/EP1637134A4/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0930962A (ja) * | 1995-07-21 | 1997-02-04 | Nisshin Oil Mills Ltd:The | 医療用油脂含有組成物 |
WO2001019158A2 (en) * | 1999-09-10 | 2001-03-22 | Ceteris Holding B.V.-Amsterdam (Olanda) - Succursale Di Lugano | An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
WO2001084961A2 (en) * | 2000-05-08 | 2001-11-15 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
Non-Patent Citations (12)
Title |
---|
BIAGI G ET AL: "PROSTANOID PRODUCTION IN VARICOSE VEINS EVIDENCE FOR DECREASED PROSTACYCLIN WITH INCREASED THROMBOXANE A-2 AND PROSTAGLANDIN E-2 FORMATION", ANGIOLOGY, vol. 39, no. 12, 1988, pages 1036 - 1042, ISSN: 0003-3197 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1988, BIAGI G ET AL: "PROSTANOID PRODUCTION IN VARICOSE VEINS EVIDENCE FOR DECREASED PROSTACYCLIN WITH INCREASED THROMBOXANE A-2 AND PROSTAGLANDIN E-2 FORMATION", XP002561253, Database accession no. PREV198987045028 * |
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; February 1992 (1992-02-01), TAMURA Y ET AL: "[Anti-thrombotic and anti-atherogenic action of eicosapentaenoic acid]", XP002561254, Database accession no. NLM1613998 * |
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; January 1998 (1998-01-01), HABÁN P ET AL: "[The effect of n-3 fatty acid administration on selected indicators of cardiovascular disease risk in patients with type 2 diabetes mellitus]", XP002561255, Database accession no. NLM9588078 * |
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; May 2003 (2003-05-01), MEGHDADI SUSAN ET AL: "8-Epi-PGF2alpha and 6-oxo-PGF1alpha in human (varicose) veins: influence of age, sex, and risk factors.", XP002561258, Database accession no. NLM12785024 * |
DATABASE WPI Week 199715, Derwent World Patents Index; AN 1997-161410, XP002561257 * |
HABÁN P ET AL: "[The effect of n-3 fatty acid administration on selected indicators of cardiovascular disease risk in patients with type 2 diabetes mellitus]", BRATISLAVSKÉ LEKÁRSKE LISTY JAN 1998, vol. 99, no. 1, January 1998 (1998-01-01), pages 37 - 42, ISSN: 0006-9248 * |
HAMAZAKI T ET AL: "Effects of orally administered ethyl ester of eicosapentaenoic acid (EPA; C20:5, omega-3) on PGI2-like substance production by rat aorta", PROSTAGLANDINS, BUTTERWORTH, STONEHAM, MA, US, vol. 23, no. 4, 1 April 1982 (1982-04-01), pages 557 - 567, XP023446850, ISSN: 0090-6980, [retrieved on 19820401] * |
MEGHDADI SUSAN ET AL: "8-Epi-PGF2alpha and 6-oxo-PGF1alpha in human (varicose) veins: influence of age, sex, and risk factors.", ANGIOLOGY 2003 MAY-JUN, vol. 54, no. 3, May 2003 (2003-05-01), pages 317 - 324, ISSN: 0003-3197 * |
SAITO J ET AL: "Mechanisms of enhanced production of PGI2 in cultured rat vascular smooth muscle cells enriched with eicosapentaenoic acid.", ATHEROSCLEROSIS JUN 1997, vol. 131, no. 2, June 1997 (1997-06-01), pages 219 - 228, XP002561256, ISSN: 0021-9150 * |
See also references of WO2004112777A1 * |
TAMURA Y ET AL: "[Anti-thrombotic and anti-atherogenic action of eicosapentaenoic acid]", NIPPON RINSHO. JAPANESE JOURNAL OF CLINICAL MEDICINE FEB 1992, vol. 50, no. 2, February 1992 (1992-02-01), pages 403 - 407, ISSN: 0047-1852 * |
Also Published As
Publication number | Publication date |
---|---|
CA2529735C (en) | 2012-07-10 |
JP4870430B2 (ja) | 2012-02-08 |
EP1637134A1 (en) | 2006-03-22 |
WO2004112777A1 (ja) | 2004-12-29 |
US20070098787A1 (en) | 2007-05-03 |
JPWO2004112777A1 (ja) | 2006-07-27 |
CA2529735A1 (en) | 2004-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1637134A4 (en) | COMPOSITION FOR THE PREVENTION AND TREATMENT OF VARICES | |
GB0221688D0 (en) | Compositions for wound treatment | |
HK1099507A1 (en) | Compositions for treating diabetes | |
AU2003299034A8 (en) | Transdermal compositions | |
IL180844A0 (en) | Compositions and methods for treating excessive bleeding | |
EP1689485A4 (en) | CARDIOELECTROMAGNETIC TREATMENT | |
GB0314210D0 (en) | Laundry treatment compositions | |
GB0314211D0 (en) | Laundry treatment compositions | |
EP1755391A4 (en) | METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES | |
EP1814478A4 (en) | TECHNIQUES FOR THE HEAT TREATMENT OF VARIZES | |
AU2003218767A1 (en) | Fabric treatment composition | |
GB0326486D0 (en) | Combination treatment | |
GB0312407D0 (en) | Treatment | |
HUP0400609A3 (en) | Wet-skin treatment compositions | |
EP1576083B8 (en) | Laundry treatment compositions | |
GB0313900D0 (en) | Laundry treatment compositions | |
PL373383A1 (en) | Medicinal composition for treating arteriosclerosis | |
GB0230026D0 (en) | Laundry treatment compositions | |
GB2398740B (en) | Skin composition | |
AU2003291461A8 (en) | Compositions for diabetes treatment and prophylaxis | |
EP1660007A4 (en) | COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF DIABETES | |
PL1867644T3 (pl) | Związki heteroarylo-tetrahydropiperydylowe przydatne w leczeniu lub zapobieganiu bólu | |
AU2003240174A8 (en) | Compositions for the treatment of edematous-firbrosclerotic panniculopathy | |
AU2002351419A1 (en) | Composition for the treatment of varicose veins | |
EP1549327A4 (en) | COMPOSITION FOR THE TREATMENT OF HEMORROIDS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20051219 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: KAKIUCHI, TOSHIHIKO |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100104 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/202 20060101AFI20060127BHEP Ipc: A61K 31/232 20060101ALI20091222BHEP Ipc: A61P 9/14 20060101ALI20091222BHEP Ipc: A61P 9/00 20060101ALI20091222BHEP Ipc: A23L 1/30 20060101ALI20091222BHEP |
|
17Q | First examination report despatched |
Effective date: 20100531 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20150106 |